Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice

被引:0
|
作者
Tong Li
Jiandong Wang
机构
[1] Beijing Obstetrics and Gynecology Hospital,Department of Gynecologic Oncology
[2] Capital Medical University,undefined
来源
BMC Cancer | / 20卷
关键词
Chimeric antigen receptor T cell; Mucin 16; Programmed cell death-ligand 1; Ovarian cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Clinical study of PD-1 disrupted anti-MUC1 CAR-T cells in patients with advanced oesophageal cancer
    Chen, S.
    Lin, Y.
    Cui, Y.
    Zhou, C.
    An, H.
    Huang, J.
    Su, Z.
    McGowan, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S186 - S186
  • [22] Successful Eradication of Established Peritoneal Ovarian Tumors in SCID-Beige Mice following Adoptive Transfer of T Cells Genetically Targeted to the MUC16 Antigen
    Chekmasova, Alena A.
    Rao, Thapi D.
    Nikhamin, Yan
    Park, Kay J.
    Levine, Douglas A.
    Spriggs, David R.
    Brentjens, Renier J.
    CLINICAL CANCER RESEARCH, 2010, 16 (14) : 3594 - 3606
  • [23] Successful eradication of established peritoneal ovarian tumors in SCID-beige mice following adoptive transfer of T cells genetically targeted to the MUC16 antigen
    Chekmasova, Alena A.
    Thapi, Dharmarao
    Nikhamin, Yan
    Park, Kay J.
    Spriggs, David R.
    Brentjens, Renier J.
    CANCER RESEARCH, 2010, 70
  • [24] CAR-T cells targeting HLA-G as potent therapeutic strategy for EGFR-mutated and overexpressed oral cancer
    Lin, Yu-Chuan
    Hua, Chun-Hung
    Lu, Hsin-Man
    Huang, Shi-Wei
    Chen, Yeh
    Tsai, Ming-Hsui
    Lin, Fang-Yu
    Canoll, Peter
    Chiu, Shao-Chih
    Huang, Wei-Hua
    Cho, Der-Yang
    Jan, Chia-Ing
    ISCIENCE, 2023, 26 (03)
  • [25] TGFß-mediated targeting of the extracellular matrix enhances the migration and cytotoxicity of CAR-T cells in 3D models of ovarian cancer
    Joy, Joash Dominic
    Malacrida, Beatrice
    Laforets, Florian
    Kotantaki, Panoraia
    Maniati, Eleni
    Hopkins, Sarah
    Calleja, Ianire
    Brett, Sara
    Athanasopoulos, Takis
    Ali, Sadfer
    Emery-Billcliff, Peter
    Ricciardelli, Ida
    Kay, Charlotte
    Colebrook, Jayne
    Ali, Magda
    Strong, Katherine
    Balkwill, Frances
    CANCER RESEARCH, 2022, 82 (12)
  • [26] ROR1-targeting switchable CAR-T cells for cancer therapy(Vol 41, Pg 4104, 2022)
    Peng, Haiyong
    Nerreter, Thomas
    Mestermann, Katrin
    Wachter, Jakob
    Chang, Jing
    Hudecek, Michael
    Rader, Christoph
    ONCOGENE, 2024, 43 (13) : 992 - 992
  • [27] CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
    Zhou, Ru
    Yazdanifar, Mahboubeh
    Das Roy, Lopamudra
    Whilding, Lynsey M.
    Gavrill, Artemis
    Maher, John
    Mukherjee, Pinku
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [28] Phase I clinical trial of MUC1-targeted CAR-T cells with PD-1-knockout in the treatment of advanced breast cancer
    Lin, Yiguang
    Yin, Haibin
    Zhou, Chao
    Zhou, Ling
    Zeng, Yanyi
    Yao, Herui
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Identification and Characterization of Fully Human FOLR1-Targeting CAR T Cells for the Treatment of Ovarian Cancer
    Bethke, Maria
    Abramowski, Pierre
    Droste, Miriam
    Felsberger, Andre
    Kochsiek, Lisa
    Kotter, Bettina
    Plettig, Luisa
    Antonova, Kateryna
    Baghdo, Salpy
    Burzan, Nico
    Tomszak, Florian
    Martinez-Osuna, Manuel
    Eckardt, Dominik
    Herbel, Christoph
    CELLS, 2024, 13 (22)
  • [30] Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition
    Yeku, Oladapo O.
    Rao, Thapi Dharma
    Laster, Ian
    Kononenko, Artem
    Purdon, Terence J.
    Wang, Pei
    Cui, Ziyou
    Liu, Hong
    Brentjens, Renier J.
    Spriggs, David
    FRONTIERS IN IMMUNOLOGY, 2021, 12